'We are pleased to support B-FLEXION and management in the creation of a scaled specialty pharmaceutical platform,' said Jonathan Brayman, Managing Director at Blackstone Credit & Insurance. 'This transaction reflects our ability to provide large-scale capital solutions to life sciences companies.' 'We are proud to partner with Blackstone on this next phase of growth for Paratek, as it is a transformative transaction for both the organization and the broader platform,' said Peter Agnes, Operating Partner at B-FLEXION Life Sciences. Subscribe to our Newsletter to increase your edge. Don't worry about the news anymore, through our newsletter you'll receive weekly access to what is happening. Join 120,000 other PE professionals today.
learn more
